These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 7197945)
1. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies. Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945 [TBL] [Abstract][Full Text] [Related]
2. Calcium blocking properties of piprofurol. Pourrias B; Huerta F; Santamaria R; Bowe C Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):223-39. PubMed ID: 4026458 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [TBL] [Abstract][Full Text] [Related]
4. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
5. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles. Nishimura K; Miyawaki N; Yamauchi H; Iso T Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000 [TBL] [Abstract][Full Text] [Related]
6. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964 [TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
8. Vasodilator mechanism of KB-944, a new calcium antagonist. Morita T; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823 [TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies. Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816 [TBL] [Abstract][Full Text] [Related]
10. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta. Flaim SF; Ratz PH; Swigart SC; Gleason MM J Pharmacol Exp Ther; 1985 Jul; 234(1):63-71. PubMed ID: 2409274 [TBL] [Abstract][Full Text] [Related]
11. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations. Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822 [TBL] [Abstract][Full Text] [Related]
12. Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle. Nawrath H; Raschack M J Pharmacol Exp Ther; 1987 Sep; 242(3):1090-7. PubMed ID: 3656109 [TBL] [Abstract][Full Text] [Related]
13. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding. Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181 [TBL] [Abstract][Full Text] [Related]
14. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries. Hondeghem LM; Ayad MJ; Robertson RM J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042 [TBL] [Abstract][Full Text] [Related]
15. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro. Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604 [TBL] [Abstract][Full Text] [Related]
16. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina. Angus JA; Brazenor RM; Le Duc MA Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of three calcium entry blockers in conscious dogs. Eigenmann R; Gerold M Arzneimittelforschung; 1987 Sep; 37(9):1020-5. PubMed ID: 3435596 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the fast Na+ inward current by the Ca2+ channel blocker tiapamil. Osterrieder W J Cardiovasc Pharmacol; 1986; 8(6):1101-6. PubMed ID: 2434733 [TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action. Osterrieder W; Holck M J Cardiovasc Pharmacol; 1989 May; 13(5):754-9. PubMed ID: 2472524 [TBL] [Abstract][Full Text] [Related]
20. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]